Publications

Patel SA, Hirosue S, Rodrigues P, Vojtasova E, Richardson EK, Ge J, Syafruddin SE, Speed A, Papachristou EK, Baker D, Clarke D, Purvis S, Wesolowski L, Dyas A, Castillon L, Caraffini V, Bihary D, Yong C, Harrison DJ, Stewart GD, Purdue MP, Chanock SJ, Warren AY, Samarajiwa SA, Carroll JS, Vanharanta S. The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer. Nature. 2022 Jun;606(7916):999-1006.

• See also comments in:
  • Arner EN and Rathmell WK. Mutation and tissue lineage lead to organ-specific cancer. Nature. 2022 Jun;606(7916):871-872.
  • Oncogenic Signaling in Kidney Cancer Requires Renal Lineage Factor PAX8. Cancer Discov. 2022 Aug 5;12(8):1834.
  • Stone L. Control of oncogenic signalling in ccRCC. Nat Rev Urol. 2022 Aug;19(8):453.

Patel SA, Rodrigues P, Wesolowski L, Vanharanta S. Genomic control of metastasis. Br J Cancer. 2021 Jan;124(1):3-12.

Syafruddin SE, Rodrigues P, Vojtasova E, Zaini MN, Patel SA, Burge J, Warren AY, Stewart GD, Eisen T, Samarajiwa SA, Vanharanta S. A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma. Nat Commun. 2019, Mar 11;10(1):1152

Rodrigues P, Patel SA, Harewood L, Olan I, Vojtasova E, Syafruddin SE, Zaini MN, Richardson EK, Burge J, Warren AY, Stewart GD, Saeb-Parsy K, Samarajiwa SA, Vanharanta S. NF-kappaB-dependent lymphoid enhancer co-option promotes renal carcinoma metastasis. Cancer Discov. 2018, Jul;8(7):850-865

All publications listed in PubMed.